Search for: "Purdue Pharma Technologies Inc" Results 21 - 40 of 40
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Nov 2016, 9:16 am by Dennis Crouch
Epic Pharma, LLC, 16-289 (whether the circumstances of invention can help prove non-obviousness) (The Purdue and Grunenthal cases stem from the same Federal Circuit decision but involve separate patents owned by the respective petitioners) Claim Construction: CSP Technologies, Inc. v. [read post]
28 Sep 2016, 8:39 am by Dennis Crouch
, No. 16-296 (OxyContin patent – when is an element ‘inherently’ disclosed by the prior art for anticipation purposes) Obviousness: Purdue Pharma L.P. v. [read post]
4 May 2011, 7:52 am by Tron Emptage
Brand Name Opioid Products Generic Name Trade Name Applicant/Sponsors Fentanyl Duragesic Extended Release Transdermal System Ortho McNeil Janssen Hydromorphone *Palladone Extended Release Capsules Purdue Pharma   Methadone Dolophine Tablets Roxanne Morphine Avinza® Extended Release Capsules King Pharms   Morphine Kadian® Extended Release Capsules Actavis   Morphine MS Contin Extended Release Tablets … [read post]
12 Nov 2014, 10:15 am
Janssen and Teva file to protect Chicago disclosing trade secrets:  Back in the summer, the city of Chicago commenced proceedings against several pharmaceutical companies, including Janssen, Purdue Pharma LP, Teva and Actavis alleging that they dishonestly marketed opioid painkillers including Oxycontin and Percocet for the treatment of common and non-cancer related chronic pain resulting in a reported public health crisis of addiction and abuse. [read post]
11 Jan 2008, 9:00 am
: (IP Spotlight)PharmaIndia: Trade mark assignment under scrutiny in a case of deceptive similarity - Doctor Morepen Limited v Yash Pharma Laboratories Limited: (Mondaq),Arrow v Merck - An early route to market for generics? [read post]
25 Jan 2010, 5:00 am by Beck, et al.
Cal. 1990); In re Wyse Technology Securities Litigation, 1990 WL 169149, at *5 (N.D. [read post]
1 Feb 2022, 4:08 pm by Ben Vernia
Civil enforcement actions against the parties responsible for triggering and fueling the opioid epidemic are a critical part of the department’s ongoing efforts to address this crisis.Consistent with this focus, the largest False Claims Act settlements in the past year resulted from significant resolutions with prescription opioid manufacturers:  Indivior Inc. and Indivior plc (Indivior), and Purdue Pharma (Purdue). [read post]
22 Mar 2018, 9:30 pm by Sarah Madigan
” The state of Arkansas sued dozens of drug makers and distributors, including Purdue Pharma Inc., over their role in the opioid epidemic. [read post]
17 Jan 2008, 10:00 pm
: (Against Monopoly),Structuring a decentralized world - Institute for Ethics and Emerging Technologies: The necessity of open biotechnology: (Patent Lens),A skeptical look at the Automated Content Access Protocol: (Ars Technica),5 practical things to incorporate in a corporate IP strategy: (IP ThinkTank), Legal models for online content enforcement: (OpenContentLawyer),Germany, Chinese copies and misdirected ‘strategy':… [read post]
3 Jul 2008, 7:26 pm
American Dental Technologies, Inc., 1995 WL 599871 (E.D. [read post]
11 May 2007, 12:52 am
OxyContin Maker, Execs Plead Guilty, Will Pay $634.5M The Associated Press Purdue Pharma L.P., the maker of the powerful painkiller OxyContin, and three of its current and former executives pleaded guilty Thursday to misleading the public about the drug's risk of addiction and will pay $634.5 million in fines, a federal prosecutor said. [read post]
5 Sep 2008, 11:01 pm
(IP finance), Microsoft and Nikon sign patent cross-licensing agreement covering consumer electronics: (Managing Intellectual Property), World day against software patents: (Spicy IP), (IPKat), Patents.com – PatentMonkey redux: (The Patent Librarian’s Notebook), Women and patents: it is not working at the moment: (IAM) Experts discuss the role of IP in environmental technology transfer: (Intellectual Propery Watch), WIPO’s 2008 World Patent Report: (The Patent… [read post]
22 Dec 2009, 8:57 pm
Purdue Pharma, 438 F.3d at 1136. [read post]